What if mosquito saliva holds the key to better fighting Zika, dengue and West Nile viruses?
· Medical Xpressedited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add to Preferred Sources
Mosquitoes do more than simply transmit the viruses they carry: Their saliva may actively help these viruses establish infection in the body from the very moment of the bite. This is the finding of a study conducted by a team from the IRD, CNRS, the University of Montpellier (France) and Mahidol University (Thailand), published in Nature Communications.
The scientists identified a viral compound in the saliva of infected mosquitoes that appears to promote infection by inhibiting the body's initial immune response. This discovery opens the door to a new vaccination strategy against mosquito-borne viruses.
A public health issue that remains poorly understood
Mosquito-transmitted orthoflaviviruses, which cause diseases like dengue, Zika and West Nile fever, represent a major public health threat, particularly in tropical and subtropical regions (Asia, South America, Africa). Dengue, Zika and West Nile viruses alone are responsible for around 500 million infections every year.
All of these viruses share one common feature: they are transmitted through mosquito bites. Yet there is still no effective treatment covering all of these diseases, and the mechanisms that allow the virus to establish itself in the skin after a bite remain largely unclear.
"Understanding how mosquito saliva influences skin infection is essential for better understanding transmission and identifying new prevention targets," said Julien Pompon, research director at IRD and FLAVIVACCINE coordinator.
A compound in saliva 'sets the stage' for infection
When an infected mosquito bites the skin, it injects saliva containing viral particles. The researchers discovered that this saliva also contains a viral RNA (ribonucleic acid) known as sfRNA, which plays an active role in establishing infection.
Using an in vivo transmission model developed at Vectopôle, an IRD laboratory based in Montpellier dedicated to vector research, the scientists demonstrated that the greater the amount of sfRNA present in the saliva, the more strongly infection is promoted.
Beyond helping establish infection, sfRNA also enhances viral spread. When a virus enters the skin, the human body triggers an innate immune response aimed at detecting the virus and limiting its replication. However, the researchers showed that once injected through saliva, sfRNA inhibits activation of this immune response, allowing the viruses to gain time at the bite site.
From the laboratory to a new vaccination strategy
The mechanism was studied in two orthoflaviviruses transmitted by two different mosquito species: West Nile virus transmitted by common mosquitoes (Culex) and Zika virus (ZIKV) transmitted by tiger mosquitoes (Aedes).
In both cases, researchers detected sfRNA in the saliva of infected mosquitoes. These findings suggest that the presence of this RNA in saliva may be a shared mechanism among several orthoflaviviruses, raising the possibility of common prevention strategies targeting not a specific virus but rather the mechanism that facilitates infection at the time of the bite.
"This discovery shows how fundamental research into transmission mechanisms can lead to a new preventive approach against several mosquito-borne viral diseases," said Pompon, research director at IRD and FLAVIVACCINE coordinator.
Building on this discovery, IRD researchers have developed a vaccination strategy targeting the identified salivary compound. This approach is currently being developed and optimized for clinical-scale application as part of the Horizon Europe Flavivaccine project, which aims to explore a prevention strategy against several endemic diseases affecting countries in the Global South.
Publication details
Idalba Serrato-Pomar et al., Multiple orthoflaviviruses secrete sfRNA in mosquito saliva to promote transmission by inhibiting MDA5-mediated early interferon response, Nature Communications (2026). DOI: 10.1038/s41467-026-77288-4
Journal information: Nature Communications
Key medical concepts
Immunity, InnateWest Nile virusZika Virus
Clinical categories
Infectious diseasesCommon illnesses & PreventionPreventive medicine Provided by iCube Programme Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: What if mosquito saliva holds the key to better fighting Zika, dengue and West Nile viruses? (2026, October 14) retrieved 14 October 2026 from https://medicalxpress.com/news/2026-10-mosquito-saliva-key-zika-dengue.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.